advisory committee on research on women's health

An official website of the United States government

Here's how you know

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

U.S. Department of Health & Human Services

Advisory Committee on Research on Women's Health

Committee Website

Meeting Type: Open

Meeting Format: Virtual

NIH Advisory Committee on Research on Women's Health

Expanding menopause research to advance the health of all women.

Posted on May 15th, 2023 by Janine Austin Clayton, M.D., FARVO, NIH Office of Research on Women’s Health

Since 2017, NIH’s Office of Research on Women’s Health (ORWH) has hosted the Vivian W. Pinn Symposium during National Women’s Health Week (NWHW ) in May. This event honors the first full-time director of the office, Dr. Vivian W. Pinn, and serves as a critical forum for experts across sectors to communicate and collaborate for the advancement of women’s health.

This week marks the beginning of the 2023 NWHW, and on May 16, ORWH will host the 7th Annual Vivian W. Pinn Symposium. It’s titled: Menopause and Optimizing Midlife Health of Women.

Topics to be discussed include: the menopausal transition (also known as perimenopause), the accumulation of morbidity after menopause, menopause in special populations, the influence of social determinants of health on the experience of menopause, the use of menopausal hormone therapy (MHT), and interventions to promote healthy aging.

This year, JoAnn Manson, Harvard Medical School, Cambridge, MA, will deliver the keynote speech, titled “Menopausal Hormone Therapy: 30 Years of Lessons from the Women’s Health Initiative.” I encourage everyone with an interest in women’s health to register for the event .

In 1992, NIH’s National Heart, Lung, and Blood Institute launched the Women’s Health Initiative (WHI ), seeking to improve the health of women through research on prevention of serious health conditions in postmenopausal women. Over three decades later, WHI remains an extraordinary example of centering research around the health needs of women, and WHI research results “ definitively established that menopausal hormone therapy should not be used to prevent heart disease, stroke, and other chronic diseases .” These results were practice-changing and led to a dramatic decline in the use of MHT.

Menopause is a natural and irreversible life course stage marked by the cessation of menstrual cycling for 12 consecutive months. Common symptoms associated with menopause include hot flashes, sleep disturbances, mood changes, headaches, and heart palpitations. An article, co-authored by Dr. Manson, summarizes effective hormonal and non-hormonal treatments to manage menopausal symptoms [1].

The WHI’s longer-term follow-up of the treatment of these women, however, has demonstrated many nuanced findings [2]. For example, MHT’s risks and benefits are complex and vary based upon patient-level characteristics, including the age at which the therapy is initiated and the formulation of the MHT prescribed. Importantly, WHI was designed to assess the efficacy of MHT in preventing chronic disease, not to assess the efficacy or safety of MHT when used to treat menopausal symptoms. The average study participant was older, with over a decade since the start of their menopausal transition.

When considering any treatment, people should consult a health care professional, and MHT may be an option for some women, especially those who are experiencing menopausal symptoms and are at low risk for adverse events. The Food and Drug Administration (FDA) offers a fact sheet to answer questions and provide guidance about menopause and hormones, and has evaluated the risks and benefits of MHT for specific age groups of women [3].

In addition to WHI, there are two other valuable NIH-funded studies helping to make progress in our understanding of the health of midlife and older women:

• Study of Women’s Health Across the Nation (SWAN )

• Menopause Strategies: Finding Lasting Answers for Symptoms and Health (MsFLASH )

A major health concern for women during perimenopause, menopause, and post menopause is cardiovascular health. More research is needed to understand how different stages of menopause affect women’s cardiovascular health and how different doses and formulations of MHT may affect risk.

Among the many speakers at the Vivian W. Pinn Symposium will be Wendy Kohrt, a co-author on a recent comprehensive review of cardiovascular health and menopause [4]. She is director of the University of Colorado Specialized Centers of Research Excellence on Sex Differences (SCORE ), Aurora. Also, a recent issue of ORWH’s Women’s Health in Focus at NIH discussed current NIH-funded research on menopause, resources, future menopause-related research, and more.

In response to a Congressional request to address NIH efforts related to women’s health research, ORWH hosted, along with the NIH Advisory Committee on Research on Women’s Health, “ Advancing NIH Research on the Health of Women: A 2021 Conference .” The importance of menopause research as it relates to chronic debilitating conditions, which pose a significant burden on the health of women, was addressed during the conference, and the full report is available on the ORWH website.

Further, ORWH and partnering institutes released two notices of funding opportunities titled Understanding Chronic Conditions Understudied Among Women (R01 and R21 ), and ORWH sponsored the forthcoming Framework for the Consideration of Chronic Debilitating Conditions in Women from the National Academies of Sciences, Engineering, and Medicine.

I wish everyone a happy and healthy NWHW and look forward to gathering virtually for the 7th Annual Vivian W. Pinn Symposium. For more information and resources on menopause, visit the FDA’s Office of Women’s Health and NIH’s National Institute on Aging (NIA ) websites. Also, My Menoplan , developed by NIA-funded researchers, offers information and personalized tools to help plan for perimenopause and menopause. Please stay connected to ORWH by visiting our website for updates ; signing up for our monthly newsletter, The Pulse ; liking us on Facebook ; and following ORWH on Twitter .

References :

[1] Management of menopausal symptoms: A review . Crandall CJ, et al. JAMA. 2023 February 7: 329(5):405-420.

[2] Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials . Manson JE, et al. JAMA. 2013 October 2: 310(13)1353-1368.

[3] Randomized trial evaluation of the benefits and risks of menopausal hormone therapy among women 50-59 years of age . Prentice RL, et al. Am J Epidemiol. 2021 February 1: 190(3):365-375. [4] Body composition and cardiometabolic health across the menopause transition . Marlatt KL, et al. Obesity. 2022 January; 30(1)14-27.

Office of Research on Women’s Health (NIH)

7th Annual Vivian W. Pinn Symposium (ORWH)

ORWH Quarterly Publication

Specialized Centers of Research Excellence on Sex Differences (SCORE ) (ORWH)

National Women’s Health Week (Office on Women’s Health, U.S. Department of Health and Human Services, Rockville, MD)

Women’s Health Initiative (WHI )

Study of Women’s Health Across the Nation (SWAN )

Menopause Strategies: Finding Lasting Answers for Symptoms and Health (MsFLASH ) (Fred Hutchinson Cancer Center, Seattle)

Office of Women’s Health (U.S. Food and Drug Administration, Silver Spring, MD)

Note : Dr. Lawrence Tabak, who performs the duties of the NIH Director, has asked the heads of NIH’s Institutes, Centers, and Offices to contribute occasional guest posts to the blog to highlight some of the interesting science that they support and conduct. This is the 30th in the series of NIH guest posts that will run until a new permanent NIH director is in place.

Share this:

• Click to share on Facebook (Opens in new window)
• Click to share on X (Opens in new window)
• Click to share on LinkedIn (Opens in new window)
• Click to share on Pinterest (Opens in new window)
• Click to share on Tumblr (Opens in new window)
• Click to share on Reddit (Opens in new window)
• Click to share on Telegram (Opens in new window)
• Click to share on WhatsApp (Opens in new window)
• Click to print (Opens in new window)

Posted In: Generic

Tags: FDA , JoAnn Manson , menopausal hormone therapy , menopause , MHT , MsFLASH , National Women's Health Week , NIH Advisory Committee on Research on Women's Health , NWHW , ORWH , perimenopause , post menopause , SWAN , Vivian Pinn , Wendy Kohrt , WHI , women , Women's Health Initiative , women's health

@NIHDirector on X

Nih on social media.

Kendall Morgan, Ph.D.

Comments and Questions

If you have comments or questions not related to the current discussions, please direct them to Ask NIH .

You are encouraged to share your thoughts and ideas. Please review the NIH Comments Policy

• Visitor Information
• Privacy Notice
• Accessibility
• No Fear Act
• HHS Vulnerability Disclosure
• U.S. Department of Health and Human Services
• USA.gov – Government Made Easy

• Board of Directors
• Job Opportunities
• The Role of Women’s Health Research
• Alopecia Areata
• Alzheimer’s Disease
• Atopic Dermatitis
• Autoimmune Diseases
• Bone Health
• Diagnostics
• Endometriosis
• Expanded Carrier Screening
• Heart Health
• HPV & Related Diseases
• Liver Health
• Maternal and Infant Health Disparities
• Noninvasive Prenatal Screening
• Osteoarthritis
• Polycystic Ovary Syndrome
• Psoriatic Arthritis
• Sleep Health
• Uterine Fibroids
• Women’s Health Equity Initiative
• Women’s Health Dashboard
• Policy Advisory Council
• Policy Engagement
• Women’s Health Policy Agendas
• Legislation Tracker
• Women’s Health Perspectives
• Strategic Partnerships
• Event Calendar
• SWHR Annual Awards Gala

58th Meeting of the NIH Advisory Committee on Research on Women’s Health

• This event has passed.

April 12, 2023 @ 9:30 am - 3:50 pm EDT

The 58th Meeting of the NIH Advisory Committee on Research on Women’s Health ( ACRWH ) will provide a forum for ACRWH members to give advice and make recommendations on priority issues affecting women’s health and sex differences research.

The NIH Revitalization Act of 1993 established the Advisory Committee on Research on Women’s Health (ACRWH), a Federal Advisory Committee Act (FACA) committee, to give advice and make recommendations on priority issues affecting women’s health and sex differences research. ACRWH members are selected from among physicians, practitioners, scientists, and other health professionals who are not federal employees.

The ACRWH’s responsibilities are to: •    Advise the ORWH director on appropriate NIH research activities in women’s health •    Review the women’s health research portfolio for NIH •    Survey goals for scientific career development •    Assess inclusion of women and minorities in NIH clinical research

• Google Calendar
• Outlook 365
• Outlook Live

• Notices of Funding Opportunities
• NIH RePORTER
• Co-Funding Activities
• BSSR Clinical Trials
• Reports and Publications
• OBSSR-Supported Training
• Online Training Resources
• OBSSR Connector Monthly Newsletter
• The Director’s Voice Blog
• Research Spotlights
• BSSR News and Announcements
• All Upcoming Events and Meetings
• NIH Behavioral and Social Sciences Research Festival
• NIH Matilda White Riley Behavioral and Social Sciences Honors
• OBSSR Director’s Webinar Series
• Mission and History
• BSSR Definition
• BSSR Accomplishments
• Strategic Plan
• NIH Behavioral and Social Sciences Research Coordinating Committee (BSSR-CC)
• Coordination of NIH-wide Initiatives
• Staff Directory

• News and Events

Advancing Women’s Health Research and Innovation: A Conversation with Janine Clayton, Director of the NIH Office of Research on Women’s Health (ORWH)

In March 2024, President Joe Biden signed an  Executive Order directing the most comprehensive set of executive actions ever to expand and improve women’s health. Its actions prioritize the integration of women’s health throughout the federal research portfolio and budget, galvanizing new research initiatives on various topics, including menopause and women’s midlife health.

The order will create a Fund for Women’s Health Research at the National Institutes of Health (NIH) to drive a cutting-edge, interdisciplinary research agenda and establish a nationwide network of research centers of excellence and innovation.

The Office of Behavioral and Social Sciences Research (OBSSR) has a history of supporting research initiatives addressing issues such as health disparities, opportunities for women in scientific fields, improvements in research inclusivity, and policy matters affecting women. We look forward to building on our collaborations with the Office of Research on Women’s Health (ORWH) to accelerate research to prevent, diagnose, and treat conditions that uniquely or disproportionately impact women.

I recently had the opportunity to connect with the Director of ORWH, Janine Clayton, M.D., FARVO about the importance of behavioral and social sciences research to women’s health and how the Executive Order can help address how we will work together to close gaps and accelerate the advancement of women's health research.

What are some of the major challenges in women’s health research that the Executive Order aims to address? 

The Executive Order focuses on five key areas to support women’s health. These include prioritizing and enhancing investments; fostering innovation and discovery; expanding and leveraging data collection and analysis; strengthening coordination, infrastructure, and training; and improving women’s health across the lifespan.

By increasing funding and focusing on women’s health across the lifespan, there is an opportunity to better understand the diseases and conditions associated with women’s midlife and later years.

What role does behavioral and social science research play in improving health outcomes for women? 

Much of the research at the NIH focuses on the biological perspectives that influence women’s health at the genetic, molecular, and physiological levels. However, it is imperative to understand how these internal factors interact with the external ones, such as social constructions of gender and sexuality and social determinants of health. These interactions have broad implications for women’s health outcomes.

Research has shown that lifestyle behaviors, such as healthy eating and regular physical activity can prevent conditions like heart attack and stroke. Simply recommending that women eat whole foods and exercise regularly does not consider how the social world influences individual behaviors. For example, some women may not have access to healthy foods because they live in an area without a grocery store. They may have physical disabilities that limit their ability to exercise or live in a neighborhood where it is not safe to be outside due to violence or air pollution.

Continued and expanded support for behavioral and social science research can enhance our understanding of the factors that influence women’s health. This support can help develop effective interventions that address health disparities and advance equity for women.

How is women’s health research linked to health equity?

To conduct equity-focused health research for women, we need to take an intersectional approach. This means looking at the differences among groups and understanding how various social factors influence women’s health outcomes.

Recognizing that women's experiences vary, it's important to tailor strategies for improving women’s health to account for these differences. For example, cultural factors significantly influence women's perceptions of menopause and affect their acceptance of biomedical approaches during this transition. Additionally, racial and ethnic minoritized groups may face obstacles in accessing proper care and can have challenges in finding menopause-related information and support.

To support equity-focused research, ORWH recently coordinated the release of a  Notice of Special Interest on women’s health that highlights the NIH’s interest in receiving research applications focused on diseases and health conditions that predominantly affect women.

The Executive Order aims to improve the recruitment, enrollment, and retention of women in clinical trials. How do behavioral or social science play a role in achieving this goal?

As the focal point for women's health research, ORWH strives to ensure that women from understudied, underrepresented, and underreported (U3) populations are included in biomedical research to reduce health disparities. Behavioral and social science can shed light on the various obstacles that affect women’s willingness and ability to participate in clinical trials, such as caregiving responsibilities, work obligations, or concerns about discomfort.

For instance, historically there has been insufficient representation of African American women in clinical research. The Executive Order aims to reduce these gaps in representation by prioritizing the inclusion of women from all racial, ethnic, and socioeconomic backgrounds in clinical research.

OBSSR and ORWH promote implementation science to enhance the impact of research findings. Are there specific areas within women's health where implementation science is particularly important?

Implementation science is critical for ensuring the retention of women in clinical trials. The Executive Order recommends using technological and data science advances to reduce women’s barriers to access. Implementation science can investigate the multiple contextual factors that could impact women’s uptake of these advances.

Integrating user-centered design and community-based participatory research approaches in the development of innovative technological and data science strategies can increase the successful implementation of these tools and potentially increase women’s participation in clinical trials.

31 Center Drive, Building 31, Room B1C19 Bethesda, MD 20892

Email: [email protected]

Phone: 301-402-1146

NIH Virtual Tour

An official website of the United States government

Here’s how you know

Official websites use .gov A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS A lock ( A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

• Heart-Healthy Living
• High Blood Pressure
• Sickle Cell Disease
• Sleep Apnea
• Information & Resources on COVID-19
• The Heart Truth®
• Learn More Breathe Better®
• Blood Diseases and Disorders Education Program
• Publications and Resources
• Blood Disorders and Blood Safety
• Sleep Science and Sleep Disorders
• Lung Diseases
• Health Disparities and Inequities
• Heart and Vascular Diseases
• Precision Medicine Activities
• Obesity, Nutrition, and Physical Activity
• Population and Epidemiology Studies
• Women’s Health
• Research Topics
• Clinical Trials
• All Science A-Z
• Grants and Training Home
• Policies and Guidelines
• Funding Opportunities and Contacts
• Training and Career Development
• Email Alerts
• NHLBI in the Press
• Research Features
• Past Events
• Upcoming Events
• Mission and Strategic Vision
• Divisions, Offices and Centers
• Advisory Committees
• Budget and Legislative Information
• Jobs and Working at the NHLBI
• Contact and FAQs
• NIH Sleep Research Plan
• < Back To Home

Thirty years later, the Women’s Health Initiative provides researchers with key messages for postmenopausal women

Researchers from the NHLBI-supported Women’s Health Initiative , the largest women’s health study in the U.S., published findings from a 20-year review that underscores the importance of postmenopausal women moving away from a one-size-fits-all approach to making medical decisions. Through this lens, the researchers encourage women and physicians to work together to make shared and individualized decisions based on a woman’s medical history, age, lifestyle, disease risks, symptoms, and health needs and preferences, among other factors. These findings support the concept of “whole-person health” and published in  JAMA .  After reviewing decades of data following clinical trials that started between 1993 and 1998, the researchers explain that estrogen or a combination of estrogen and progestin, two types of hormone replacement therapies, had varying outcomes with chronic conditions. The evidence does not support using these therapies to reduce risks for chronic diseases, such as heart disease, stroke, cancer, and dementia. However, the authors caution that the study was not designed to assess the effects of FDA-approved hormone therapies for treating menopausal symptoms . These benefits had been established before the WHI study began.  Another finding from the study is that calcium and vitamin D supplements were not associated with reduced risks for hip fractures among postmenopausal women who had an average risk for osteoporosis. Yet, the authors note women concerned about getting sufficient intake of either nutrient should talk to their doctor. A third finding was that a low-fat dietary pattern with at least five daily servings of fruits and vegetables and increased grains did not reduce the risk of breast or colorectal cancer, but was associated with reduced risks for breast cancer deaths. 

Media Coverage

• The Women's Health Initiative trials: clinical messages
• HRT for menopause is safe for some women, new study shows
• Major study supports safety of HRT in early menopause
• Hormone therapy for menopause doesn't reduce heart disease risk
• No need to fear menopause hormone drugs, finds major women's health study
• Researchers review findings and clinical messages from the Women’s Health Initiative 30 years after launch

• Even more »

Account Options

• Try the new Google Books
• Advanced Book Search
• Download EPUB
• Download PDF

Get this book in print

• On Demand Books
• Find in a library
• All sellers  »

Selected pages

Other editions - View all

Common terms and phrases, bibliographic information.

• Skip to main content
• Skip to FDA Search
• Skip to in this section menu
• Skip to footer links

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

U.S. Food and Drug Administration

•   Search
•   Menu
• For Consumers
• Women's Health

National Women's Health Week (NWHW)

From the FDA Office of Women's Health

National Women’s Health Week (NWHW) is an annual observance that begins on Mother’s Day and encourages women and girls to prioritize their health. Each year, FDA Office of Women’s Health (OWH) chooses a theme to inspire women to learn more about their health and take action to live their healthiest lives.

National Women's Health Week 2024

This year, NWHW is observed May 12–18, 2024. NWHW is a reminder for women of all ages to prioritize their health. FDA OWH’s NWHW 2024 theme is Know Your Bones , to empower women to take charge of their bone health, including preventing and managing osteoporosis . It’s never too early or too late to protect your bone health.

Bone health is often overlooked until problems arise. While anyone can get osteoporosis—a disease that causes very weak bones that break easily—it is about four times more common in women than men. 

Prioritizing bone health is essential for maintaining overall wellbeing throughout life. Building strong bones during childhood and the teen years is important to help prevent osteoporosis later in life. FDA OWH encourages all women to use NWHW 2024 as an opportunity to be proactive and learn about their bone health now to help prevent osteoporosis. 

Learn more about the importance of bone health for women in our latest Knowledge and News on Women’s Health (KNOWH) blog post and download our osteoporosis fact sheet to learn more about risk factors, treatment and lifestyle changes you can make to lower your risk of developing this disease.

On this page:

• Register to attend: Osteoporosis webinar (CE credits available)
• Download NWHW Partner Toolkit
• Tips for better health

REGISTER TODAY ! Osteoporosis: A Perspective for 2024 (CE credits available) May 16, 2024, 12:00 PM – 1:00 PM ET 

Health care providers and public health professionals

We’ve compiled digital and print resources for you to share valuable information with your friends, family, community, and patients. 

DOWNLOAD -  NWHW 2024 Social Media Partner Toolkit with resources for women and health care professionals, including sample social media messages and blog posts.

Throughout the week, you’ll get to Know Your Bones better by learning about different osteoporosis-related topics on FDA social media channels. Follow FDA OWH on X (Twitter) and U.S. FDA on Facebook and Instagram to learn more about these topics. 

Join OWH in celebrating 30 years of working across FDA to advance the understanding and treatment of women’s health conditions and expand women’s access to health and safety information . 

This National Women’s Health Week learn steps you can take for better health

To improve your overall physical and mental health:

• Get regular checkups, including your annual well visit . Talk to your health care provider about any health concerns you have.
• Get active .
• Eat a heart healthy and balanced diet.
• Prioritize your mental health and learn how to cope with stress .
• Practice healthy behaviors, including limiting alcohol intake and improving/getting quality sleep .

Visit the U.S. Department of Health and Human Services (HHS) Office on Women’s Health (OWH) NWHW webpage to learn more about their theme for this year: “ Empowering Women, Cultivating Health: Celebrating Voices, Wellness, and Resilience. ”

Related links 

• Osteoporosis En Espanol 
• Osteoporosis Causes & Symptoms (NIAMS) 
• Osteoporosis (HHS Office on Women's Health) 
• National Women's Health Week (HHS Office on Women's Health ) 

An official website of the United States government

Here’s how you know

Official websites use .gov A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS A lock ( Lock Locked padlock icon ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

In Crisis? Call or Text 988

Your browser is not supported

Switch to Chrome, Edge, Firefox or Safari

Page title Biden-Harris Administration Announces Maternal Mental Health Task Force’s National Strategy to Improve Maternal Mental Health Care Amid Urgent Public Health Crisis

The U.S. Department of Health and Human Services (HHS) announced the release of a national strategy today, with recommendations developed by the Task Force on Maternal Mental Health , a subcommittee of the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Advisory Committee for Women’s Services, to address the urgent public health crisis of maternal mental health and substance use issues. The Report to Congress (PDF | 2.1 MB) and accompanying National Strategy to Improve Maternal Mental Health Care (PDF | 3.6 MB)  are part of broader federal efforts to address women’s overall health, and maternal health in particular, across the nation, consistent with the White House Blueprint for Addressing the Maternal Health Crisis (PDF | 913 KB)  and the White House Initiative on Women’s Health Research .

The United States has the highest maternal mortality rate among high-income countries. Deaths from suicide, drug overdoses, and other causes related to mental health and substance use issues are the leading cause of pregnancy-related deaths in the U.S., accounting for more than 22% of those deaths. An estimated one in five individuals are impacted by mental health conditions – including mood disorders, anxiety disorders, trauma-related disorders, obsessive-compulsive disorder, and postpartum psychosis – and substance use disorders (SUD) during pregnancy and the postpartum period and disproportionately affect Black and American Indian/Alaska Native individuals and others in under-resourced communities.

“Addressing the maternal mental health crisis is a top priority for the Biden-Harris Administration. Many of these tragic deaths can be prevented by eliminating health disparities and understanding the impact of mental health during pregnancy and in the first months as a parent,” said HHS Secretary Xavier Becerra. “We want to address the challenges people are facing, decrease stigma associated with these challenges, and improve access to support both inside and outside of the health care system. I want to thank the task force for developing recommendations on how we can work to expand access to equitable treatment that will improve outcomes and help families thrive.”

“At HHS we are working every day to transform behavioral health. This critically includes providing support for maternal mental health,” said HHS Deputy Secretary Andrea Palm. “This report, and the accompanying National Strategy, will further our efforts to improve access to care – including the integration of perinatal behavioral health care across our health and social systems.”

The Task Force on Maternal Mental Health is co-chaired by Admiral Rachel Levine , M.D., HHS Assistant Secretary for Health, which oversees the Office on Women’s Health, and Miriam E. Delphin-Rittmon , Ph.D., HHS Assistant Secretary for Mental Health and Substance Use and the leader of HHS’s SAMHSA.

The task force is a subcommittee of the Advisory Committee for Women's Services which is a federal advisory committee made up of more than 100 federal and nonfederal members, including experts in obstetrics and gynecology, maternal and child health, clinical and research, psychiatry, psychology, counseling, gender-based violence, strategic policy, community behavioral health, federal-community partnerships and those with lived experience.

“This announcement is the result of the Task Force on Maternal Mental Health’s efforts to support ways to address the nation’s maternal mental health crisis,” said Admiral Rachel Levine, Assistant Secretary for Health. “The effort this task force put forth in developing comprehensive recommendations on ways to address the maternal mental health crisis is important towards informing HHS’ strategy moving forward. We look forward to reviewing the recommendations proposed in National Strategy to Improve Maternal Mental Health Care to improve maternal mental health outcomes.”

“Untreated maternal mental health and substance use conditions can have negative and long-lasting effects on individuals and families; in the worst cases, these issues result in needless deaths,” said Assistant Secretary Delphin-Rittmon. “Many of these deaths are preventable, and we are grateful for the task force’s recommendations included in this National Strategy to address these critical challenges.”

In the national strategy, the task force vision calls for a seamless integration of perinatal mental health and substance use care across medical, community, and social systems that increases equity and access, improves federal coordination, and elevates culturally relevant supports and trauma-informed approaches.

Building upon existing federal government efforts, the task force outlines a path to achieve the vision in the national strategy within a framework of five core pillars, each with supporting priorities and recommendations.

The five pillars of the national strategy focus on: building a national infrastructure that prioritizes perinatal mental health and well-being, with a focus on reducing disparities; making care and services accessible, affordable, and equitable; using data and research to improve outcomes and accountability; promoting prevention and engaging, educating, and partnering with communities; and lifting up the voices of people with lived experience.

The national strategy is a living document that will be regularly updated by the task force. The federal government will consider the strategy as it continues addressing the maternal mental health crisis.

The National Maternal Mental Health Hotline provides free, confidential, 24/7 mental health support for moms and their families before, during, and after pregnancy. Counselors are available in English and Spanish, and interpreters are available to support callers in 60 other languages. Call or text 1-833-TLC-MAMA (1-833-852-6262).

If you or someone you know is struggling or in crisis, help is available. Call or text 988 or chat 988lifeline.org .

To learn how to get support for mental health, drug, and alcohol issues, visit FindSupport.gov . Anyone seeking treatment for mental health or substance use issues should call SAMHSA’s National Helpline at 800-662-HELP (4357) or visit findtreatment.samhsa.gov .

Reporters with questions should send inquiries to [email protected] .

The Substance Abuse and Mental Health Services Administration (SAMHSA) is the agency within the U.S. Department of Health and Human Services (HHS) that leads public health efforts to advance the behavioral health of the nation. SAMHSA’s mission is to lead public health and service delivery efforts that promote mental health, prevent substance misuse, and provide treatments and supports to foster recovery while ensuring equitable access and better outcomes.

Last Updated: 05/14/2024

• U.S. Department of Health & Human Services

• Virtual Tour
• Staff Directory
• En Español

You are here

News releases.

News Release

Friday, April 18, 2008

Three New Members Named to NIH Advisory Committee on Research on Women's Health

Three new members have been appointed to the National Institutes of Health (NIH) Advisory Committee on Research on Women's Health (ACRWH), which held its semiannual meeting on March 17 in Bethesda, Maryland. The new members are: Linda C. Giudice, M.D., Ph.D., who is the Robert B. Jaffe, M.D., Endowed Professor and Chair of the Department of Obstetrics, Gynecology and Reproductive Sciences at the University of California, San Francisco; Nancy H. Nielsen, M.D., Ph.D., who is the Senior Associate Dean, State University of New York at Buffalo School of Medicine and Biomedical Sciences, and also the President-elect of the American Medical Association (AMA); and Debra Toney, Ph.D., R.N., who is the President of the National Black Nurses Association (NBNA) and the Administrator, Rainbow Medical Centers, Las Vegas, Nevada.

The NIH Revitalization Act of 1993 charges the Advisory Committee with advising the Director of the Office of Research on Women's Health on appropriate research activities to be undertaken by the national research institutes with respect to women's health research and recommendations regarding the inclusion of women in clinical trials and opportunities for women in biomedical careers. The committee is composed of up to 18 members who are appointed by the NIH Director.

Dr. Giudice is a biochemist, gynecologist, and reproductive endocrinologist whose research focuses on endometrial biology and placental-uterine interactions, as well as environmental impacts on reproductive health. She is recognized for her extensive knowledge on the topics of endometriosis, implantation and ovulatory disorders, infertility, and assisted reproduction. She recently chaired the NIH Reproductive Medicine Network and was on the Board of Directors of the American Society for Reproductive Medicine from 2002–2007. She currently sits on the Society for Women's Health Research Board of Directors and the Institute of Medicine Health Sciences Policy Board.

Long active in organized medicine, Dr. Nielsen, who has served as Speaker of the House of Delegates of the Medical Society of the State of New York and as Speaker of the AMA House of Delegates, was named president-elect of the AMA in June 2007. Following a year-long term as president-elect, Dr. Nielsen will assume the office of AMA president in June 2008. She will be the second woman to hold the AMA's highest elected office. Dr. Nielsen helped formulate policy positions for the AMA House of Delegates on such issues as depression, alcoholism among women, Alzheimer's disease, and priorities in clinical preventive services. Dr. Nielsen is active at the national level in a variety of quality initiatives including the Institute of Medicine's Roundtable on Evidence Based Medicine and the Consumer Empowerment Committee of America's Health Information Community. A board certified internist, she has been named a Master of the American College of Physicians.

Elected the 10th President of the NBNA in November 2007, Dr. Toney will be installed as NBNA President on August 5, 2008. With over 28 years of experience in health care leadership roles in family practice management, ambulatory care, outpatient diagnostics, hospitals and home health care, she is currently responsible for the oversight of six primary/urgent care centers and an outpatient diagnostic center in Las Vegas, Nevada. Dr. Toney, a Robert Wood Johnson Executive Nurse Fellow, is the president/owner of TLC Healthcare Services, a licensed home healthcare agency specializing in private duty nursing and supportive care services. She developed the Men's Health Network and is a board member of the Jourdain Kasey Foundation, which is dedicated to increasing awareness and early detection of ovarian cancer. The recipient of numerous awards, Dr. Toney frequently speaks on leadership, men and women's health, and policy and practice issues at the national and local levels.

Continuing ACRWH members include:

Vivian W. Pinn, M.D., , Chairperson, Associate Director for Research on Women's Health, Director, Office of Research on Women's Health (ORWH), NIH, Bethesda, MD; Joyce Rudick , Executive Secretary, Director, Programs and Management, ORWH, NIH, Bethesda, MD; Alan M. Krensky, M.D., Ex-Officio, Director, Office of Portfolio Analysis and Strategic Initiatives, Office of the Director, NIH, Bethesda, MD; Luther Clark, M.D. , Executive Director, Atherosclerosis, External Medical and Scientific Affairs, Cardiovascular/Metabolic Business Unit, Merck and Company, North Wales, PA; PonJola Coney, M.D. , Senior Associate Dean for Faculty Affairs, Virginia Commonwealth University, Richmond, VA; Andrea Dunaif, M.D. , Charles F. Kettering Professor of Medicine and Chief, Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University, Chicago, IL; Ronald S. Gibbs, M.D. , Professor and Chairman, Department of Obstetrics and Gynecology, University of Colorado Healthsciences Center, Denver, CO; Constance A. Howes, J.D. , President and CEO, Women and Infants Hospital, Providence RI; Scott J. Hultgren, Ph.D., Helen L. Stoever Professor of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO; Linda M. Kaste, D.D.S., Ph.D. , Associate Professor and Director of Predoctoral Dental Public Health, University of Illinois at Chicago, Chicago, IL; Nancy Norton , Founder and President, International Foundation for Functional Gastrointestinal Disorders, Milwaukee, WI; Mary Beth O'Connell, Pharm.D. , Associate Professor, Wayne State University, Detroit MI; Mary I. O'Connor, M.D. , Chair, Department of Orthopedic Surgery, Department of Orthopedics, Mayo Clinic, Jacksonville, FL; Eugene P. Orringer, M.D. , Executive Associate Dean for Faculty Affairs and Faculty Development, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; Sally Rosen, M.D. , Special Assistant, Office of the Provost Director, Center for Women's Health Research, Leadership and Advocacy, Office of the Vice President for Research, Temple University, Philadelphia, PA; Susan P. Sloan, M.D. , Program Director, Internal Medicine, Drexel University's College of Medicine, Easton, PA; Barbara Yee, Ph.D. , Professor and Chair, Department of Family and Consumer Sciences, University of Hawaii at Manoa, Honolulu, HI; and Carmen D. Zorrilla, M.D. , Professor OB-GYN, University of Puerto Rico School of Medicine, San Juan, PR.

The Office of Research on Women's Health (ORWH), Office of the Director, National Institutes of Health (NIH) serves as a focal point for women's health research at the NIH. For more information about NIH's Office of Research on Women's Health, visit http://orwh.od.nih.gov/ and for additional information on the ACRWH, go to http://orwh.od.nih.gov/about/advisory.html .

The Office of the Director, the central office at NIH, is responsible for setting policy for NIH, which includes 27 Institutes and Centers. This involves planning, managing, and coordinating the programs and activities of all NIH components. The Office of the Director also includes program offices which are responsible for stimulating specific areas of research throughout NIH. Additional information is available at http://www.nih.gov/icd/od/index.htm .

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov .

NIH…Turning Discovery Into Health ®

Connect with Us

• More Social Media from NIH

A .gov website belongs to an official government organization in the United States.

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

• Risk Factors
• Breast Cancer Resources to Share
• What CDC Is Doing About Breast Cancer
• Advisory Committee on Breast Cancer in Young Women
• MMWR Appendix
• National Breast and Cervical Cancer Early Detection Program
• Bring Your Brave Campaign

Roster of the Advisory Committee on Breast Cancer in Young Women

What to know.

This advisory committee helps CDC develop evidence-based approaches to advance understanding and awareness of breast cancer among young women.

Executive Secretary

Kimberly e. smith, mba, mha, designated federal official.

Office of Policy, Partnerships, and Communication

Division of Cancer Prevention and Control

Centers for Disease Control and Prevention

4770 Buford Highway NE, MS S107-4

Atlanta, GA 30341

Phone: 404-498-0073

Fax: 770-488-4760

Email: [email protected]

Committee Management Specialist

Carolyn p.r. headley, msph, cgmp, public health analyst.

Phone: 770-488-4237

Email: [email protected]

Cristina M. Checka, MD

Associate Professor

Breast Surgical Oncology

The University of Texas MD Anderson Cancer Center

League City, TX

Email: [email protected]

Term: May 17, 2021 to November 30, 2024

Dr. Cristina M. Checka is an assistant professor in the Department of Breast Surgical Oncology, Division of Surgery at The University of Texas MD Anderson Cancer Center. She works within a community-based practice that is uniquely positioned in the longitudinal care of young women.

Dr. Checka's day-to-day work involves breast cancer risk assessment and reduction, survivorship, and the surgical treatment of breast cancer. Her clinical interests include management of women with an increased risk of and with breast cancer. Dr. Checka has worked closely with young, underserved breast cancer patients in urban settings, as well as with rural patients who have unique travel and cost challenges. Dr. Checka earned her medical degree from Michigan State University, completed her residency in general surgery at Eastern Virginia Medical School, and completed her breast surgical oncology fellowship in 2008 at New York University.

Anne H. Blaes, MD, MS

Professor, Department of Medicine, Hematology, Oncology, and Transplantation

University of Minnesota

Minneapolis, MN

Email: [email protected]

Term: November 26, 2023 to November 30, 2026

Dr. Anne Blaes is a professor in hematology and oncology at the University of Minnesota, where she also serves as the division director of Hematology, Oncology, and Transplantation. She is the director of Cancer Survivorship Services and Translational Research and co-director of the Screening, Prevention, Etiology, and Cancer Survivorship Program in the Masonic Cancer Center. She is an active hematologist and medical oncologist with a special interest in breast cancer, cardio-oncology and cancer survivorship. She is a past chair of the American Society of Clinical Oncology Cancer Survivorship Committee. She serves on the planning committee for the San Antonio Breast Cancer Symposium, the International Cardio-Oncology Society leadership teams, and the American Heart Association Cardio-Oncology Council.

Heather Caro, MBA-HM, BSN

Manager, Alliance Management

Coeur d'Alene, ID

Email: [email protected]

Term: May 13, 2021 to November 30, 2024

Ms. Heather Caro is a manager of alliance management. She is a registered nurse with experience in intensive care, cardiology research, and the pharmaceutical industry and a freelance writer. Despite more than 15 years of experience as a nurse, her most valuable resource has been as a patient, having been diagnosed with invasive breast cancer in 2012 at age 32. Since completing her treatment, she has dedicated herself to helping others through advocacy. She serves as Idaho state lead for the Young Survival Coalition and as a consumer reviewer with the US Department of Defense Breast Cancer Research Program.

Ashley Dedmon, MPH, CHES®

Breast Cancer Patient and Research Advocate

Email: [email protected]

Term: April 1, 2022 to November 30, 2025

Ms. Ashley Dedmon is a native Houstonian. She holds a bachelor of science degree in Community Health from Prairie View A&M University. She also earned a master of public health from Florida A&M University. She is a certified health education specialist and holds a Lean Six Sigma green belt. Ashley has a diverse and multisectoral career background, including in nonprofit education, health care, policy, and government. Her experience has positioned her with unique business acumen.

Ms. Dedmon is a BRCA2+ previvor and was a teen caregiver of two parents with cancer. During her journey, she authored The Big Discovery, a children's book that guides families through a breast cancer diagnosis. She is a research advocate with Houston Methodist Research Institute and a member of the National Cancer Institute, National Institutes of Health Physical Sciences-Oncology Advocacy Network, and the Penn Medicine Basser Center for BRCA Young Leadership Council. She volunteers with the Tigerlily Foundation on various health equity initiatives, Facing Our Risk of Cancer Empowered (FORCE) as a peer navigator, and Angels Surviving Cancer. Ms. Dedmon serves on a myriad of related workgroups and committees and has presented at institutions such as MD Anderson Cancer Center, Yale University, Houston Methodist Research Institute, and CURE ® Education. When she is not working, she loves to spend time with family and work out.

Jana E. Halaby, MBA

Senior Director, Corporate Strategy

La Jolla, CA

Email: [email protected]

Term: May 12, 2021 to November 30, 2024

Ms. Jana Halaby is the senior director of corporate strategy at Illumina. She has more than 15 years of strategy, marketing, and brand-building experience across an array of industries, giving her a unique perspective on various issues. Her experience across the health care system includes optimizing operations in major health systems, advancing disease self-management through education, and developing and interpreting research to design oncology support programs. Ms. Halaby is also a breast cancer survivor who has a passion for self-advocacy. Her approach to informing herself and others is rooted in a combination of data, evidence, and compassion.

Arin Ahlum Hanson, MPH, CHES

Director of Outreach

• Living Beyond Breast Cancer

Bala Cynwyd, PA

Email: [email protected]

Term: April 4, 2022 to November 30, 2025

Ms. Arin Ahlum Hanson directs Living Beyond Breast Cancer's (LBBC) strategy for engagement and outreach to under-resourced and special populations, health care providers, and volunteers. As LBBC's director of outreach, she manages LBBC's Young Women's Initiative, which provides educational programs, resources, and support services to women diagnosed with breast cancer before age 45 and educational offerings to health care providers who serve this unique patient population. Ms. Ahlum Hanson has 17 years of experience as a nonprofit program director developing, implementing, and evaluating public health programming for under-resourced populations. She has worked at LBBC since 2009. She lives a dual city and country life by living in West Philadelphia and rural Maryland, with her husband and son.

Samantha Lynn Heller, PhD, MD, FSBI

Associate Professor of Radiology

Perlmutter Cancer Center

New York University School of Medicine

New York, NY

Email: [email protected]

Term: March 31, 2022 to November 30, 2025

Dr. Samantha Lynn Heller is an associate professor of radiology in the Breast Imaging section at the New York University Grossman School of Medicine. She is committed to improving screening outcomes and utilization as well as breast imaging specificity. Dr. Heller is the associate section chief of breast imaging and a director for radiology quality and safety at NYU Langone Health. Dr. Heller graduated from Harvard College and received her doctorate in English literature at Columbia University. She obtained her medical degree from Weill Cornell Medical School followed by an internship at Memorial Sloan Kettering and radiology residency and fellowship training at NYU. After her fellowship, she worked as a breast radiologist in the United Kingdom in the National Health South West London Breast Cancer Screening Service before joining the faculty of NYU School of Medicine.

Michael A. Howard, MD

Clinical Associate Professor of Surgery

Northwestern Medicine

Division of Plastic Surgery

Lake Forest, IL

Email: [email protected]

Term: May 14, 2021 to November 30, 2024

Dr. Michael A. Howard is the clinical associate professor of surgery in the Division of Plastic Surgery at Northwestern Medicine. He is a board-certified plastic surgeon. His practice focuses on reconstructive and aesthetic breast surgery. Dr. Howard's innovative techniques and experience with reconstruction following nipple-sparing mastectomy led to an invitation to co-lead a recurring instructional course for plastic surgeons on this topic at the American Society of Plastic Surgeons' annual meeting. Dr. Howard devotes significant time to education and clinical research. Outside of his medical practice, in keeping with his family's own experience with breast cancer and the breast cancer (BRCA) gene, Dr. Howard serves on the medical expert panel at Bright Pink, an organization focused on young women at high risk for breast and ovarian cancer.

Leigh Hurst

Founder and Executive Director

Feel Your Boobies Foundation ®

Harrisburg, PA

Email: [email protected]

Ms. Leigh Hurst is the founder and executive director of the Feel Your Boobies Foundation. She is a recognized leader in breast cancer advocacy and a noted social entrepreneur. She is a breast cancer survivor, having been diagnosed at age 33. Her organization, founded in 2004, was the first to focus on the innovative use of technology and social media to promote proactive breast health in young women. Ms. Hurst is a seasoned professional with more than 25 years of design experience and a deep expertise in eLearning, business, and management consulting. She has a unique pedagogical understanding of both cognitive and behavioral learning sciences and their application to technology solutions that create behavior change.

Jennifer Rose Klemp, PhD, MPH, MA

Director of Cancer Survivorship

The University of Kansas Cancer Center

Westwood, KS

Email: [email protected]

Term: November 27, 2023 to November 30, 2026

Dr. Jennifer Rose Klemp is a professor of medicine in the Division of Medical Oncology, the director of cancer survivorship, and the co-program leader for cancer prevention and control at The University of Kansas Cancer Center. Her clinical research practice focuses on cancer genetics and cancer survivorship. Dr. Klemp serves on several national boards, is a subject matter expert in cancer genetics and survivorship, and has peer-reviewed funding. She has presented nationally on cancer genetics, shared decision-making regarding options to manage cancer risk and survivorship issues (including lifestyle modification), and the development and implementation of cancer genetics, survivorship, and navigation programming. In addition to her roles at The University of Kansas Medical Center, she is the Vice President of Global Biopharma Business Development Lead, Biopharma Trials and Networks, at Caris Life Sciences.

Maryam B. Lustberg, MD, MPH

Yale School of Public Health

Department of Internal Medicine

Yale Cancer Center

New Haven, CT

Email: [email protected]

Term: April 18, 2022 to November 30, 2025

Dr. Maryam B. Lustberg is a breast medical oncologist. She serves as chief of breast oncology and director of the Breast Center at Yale Cancer Center in New Haven, Connecticut. She is the co-chair of symptom intervention for Alliance Clinical Trials and president of MASCC, an international organization devoted to improving cancer supportive care. She treats men and women with all stages of breast cancer with a focus on personalizing all aspects of cancer care. Dr. Lustberg received her medical degree from the University of Maryland, where she completed her residency. She completed a fellowship in medical oncology and breast medical oncology at Ohio State University before joining the faculty in 2010. She earned a master's degree in public health from Ohio State University in 2013.

Rebecca Muñoz, MPH, CHES®

Breast Cancer Survivor and Patient Advocate

Del Valle, TX

Email: [email protected]

Term: March 31, 2022 to November 30, 2023

Ms. Rebecca Muñoz is a young adult breast cancer survivor, diagnosed with triple positive breast cancer in 2017. As she approached her treatment, she experienced many barriers as she attempted to receive cold capping to preserve her hair—and her identity—during her chemotherapy. In 2018, she founded Chemotherapy Cold Cappers, the first global peer-to-peer network to support individuals and their loved ones using scalp cooling methods while undergoing chemotherapy.

Ms. Muñoz is passionate about serving the cancer community and her work focuses on patient research and advocacy. She holds a master of public health degree from Baylor University and a bachelor of arts in organizational and corporate communication from the University of Texas at El Paso. In 2021, she participated in the Éxito Latino Cancer Research Leadership Training by the Institute for Health Promotion Research at UT Health San Antonio. She is pursuing her EdD degree in learning and organizational change with a focus on patient education at Baylor University. She also serves on the Livestrong Cancer Institute's young adult and community cancer advisory boards.

Heather Ochs-Balcom, PhD

Department of Epidemiology and Environmental Health

University at Buffalo, School of Public Health and Health Professions

Buffalo, NY

Email: [email protected]

Term: May 12, 2021 to November 30, 2023

Dr. Heather Ochs-Balcom is an associate professor in the Department of Epidemiology and Environmental Health at the University at Buffalo, School of Public Health and Health Professions. She has an active research program characterizing how genes contribute to disparities in breast cancer risk for African American women. She has published on her experiences with minority recruitment to cancer epidemiology studies and has been recognized for these efforts. Dr. Ochs-Balcom is committed to the study of cancer health disparities and shedding light on how inherited and behavioral factors contribute to breast cancer risk. She is an outstanding independent researcher whose work is centered on the genetic epidemiology of cancer, particularly breast cancer, with a focus on health disparities.

Melissa A. Peters, CPO, MSPO

Survivor, Founder, Executive Director

Young Breast Cancer Project

Sisters, OR

Email: [email protected]

Term: March 31, 2022 to November 30, 2024

Ms. Melissa A. Peters is a breast cancer survivor and founder and executive director of the nonprofit Young Breast Cancer Project. At 34, with no family history of disease, Ms. Peters faced a delayed diagnosis of 11 months while pregnant. Her primary care physician, obstetrician, and radiologist did not express concerns about her breast health. Four days before giving birth, she was diagnosed with stage IIB invasive ductal carcinoma, and soon learned that she has the BRCA1 gene. While in treatment, she started photographing other young women to raise awareness. Through this work, titled the Breast Cancer Portrait Project, Ms. Peters captured 100 diagnosis stories of adolescent and young adult breast cancer. Her efforts have evolved into community-based research to quantify why women are slipping through the cracks.

Jasmine Dionne Souers

President and Chief Executive Officer

The Missing Pink

Jacksonville, FL

Email: [email protected]

Ms. Jasmine Souers is a passionate advocate for young women and people of color affected by breast cancer. Diagnosed with breast cancer at age 26 in 2016, Ms. Souers turned her pain into purpose through volunteerism and advocacy. She co-founded For the Breast of Us, the first inclusive breast cancer community for all women of color. Today, she is the CEO of The Missing Pink Breast Cancer Alliance, connecting change agents to improve the lives of people of color affected by breast cancer. She is a board member for GRASP and lends her experiences and expertise to organizations such as Young Survival Coalition, Metastatic Breast Cancer Alliance, Living Beyond Breast Cancer, the Black Women's Health Imperative, and the American Cancer Society's National Breast Cancer Roundtable.

Ex-officio members

Agency for healthcare research and quality, kisha i. coa, phd.

Dr. Kisha I. Coa is the director of the Division of Priority Populations in the Office of Extramural Research, Education, and Priority Populations at the Agency for Healthcare Research and Quality (AHRQ). Prior to joining AHRQ, Dr. Coa was a program officer at the Patient-Centered Outcomes Research Institute, where she oversaw a portfolio of comparative clinical effectiveness research studies focused on health disparities and health systems. Previously, she conducted research in the areas of digital health, cancer control, health behavior change, and health communications. Dr. Coa earned a bachelor's degree in sociology from the University of Pittsburgh, an MPH in Health Behavior and Health Education from the University of North Carolina Gillings School of Global Public Health, and a PhD in social and behavioral sciences from the Johns Hopkins Bloomberg School of Public Health.

Department of Health and Human Services Office on Women's Health

Health resources and services administration, nancy mautone-smith, msw, lcsw.

Ms. Nancy Mautone-Smith is the director of the Health Resources and Services Administration (HRSA) Office of Women's Health. In this role, she leads cross-agency initiatives and consultations to advance the health, safety, and well-being of women served by HRSA programs. She oversees activities and initiatives that support the prevention of intimate partner and interpersonal violence, care coordination for women with opioid use disorder, and advancement of cervical health within HRSA settings of care. Ms. Mautone-Smith previously served as the deputy director of the Office on Women's Health from 2016 to 2020.

Prior to coming to HRSA, she served at the US Department of Health and Human Services Office of Population Affairs Headquarters in Rockville, Maryland, where she led service delivery program activities of the Title X family planning program. She also worked at the Region 9 Office of the Regional Health Administrator, where she oversaw Title X family planning programs throughout the region. In particular, she enjoyed developing and bringing in-person training and technical assistance to award recipients in the Pacific Region, including Guam, American Samoa, the Commonwealth of the Northern Mariana Islands, the Federated States of Micronesia, the Republic of Palau, and the Republic of the Marshall Islands. A graduate of the University at Buffalo School of Social Work, Ms. Smith received the 2015 Distinguished Alumni Award for her noteworthy contributions to the social work profession. She retired from the US Public Health Service in 2020 after a career spanning 20 years. Ms. Smith is also a proud Air Force veteran and served as a clinical social worker within mental health and family maltreatment programs at Travis Air Force Base and Vandenberg Air Force Base in California.

Indian Health Service

National institutes of health, jung-min lee, md.

Dr. Jung-Min Lee is the assistant clinical investigator in the Women's Malignancies Branch of the National Cancer Institute. Dr. Lee is a graduate of Yonsei University, Wonju College of Medicine in South Korea. She completed residency training in internal medicine at Albert Einstein Medical College, followed by a clinical research fellowship on breast cancer functional imaging at the Memorial Sloan-Kettering Cancer Center in New York. Dr. Lee came to the National Cancer Institute for medical oncology training in the Medical Oncology Branch. Subsequently, she joined the Molecular Signaling Section of the Women's Cancers Clinic to investigate potential biomarkers and develop rational combinations of targeted therapies for rare subsets of women's cancers. Dr. Lee maintains her clinical focus in the development of early clinical trials for ovarian cancer and rare subsets of women's cancers, such as BRCA1/2 mutation carriers with ovarian and breast cancers, or women with triple-negative breast cancer. Dr. Lee is a member of the Gynecologic Oncology Group, American Association for Cancer Research, American Society for Clinical Oncology, and the Breast and Gynecologic Malignancies Faculty of the National Cancer Institute's Center for Cancer Research.

Liaison representatives

• American Cancer Society
• American College of Obstetrics and Gynecology

Myrlene Jeudy, MD

Assistant Professor in Obstetrics and Gynecology

1250 East Marshall Street, 6th Floor

PO Box 980034

Richmond, VA 23298

Phone: 804-828-7877

Fax: 804-628-3585

Email: [email protected]

• Black Women's Health Imperative
• Breastcancer.org

Lisa N. Kline

Vice President, Marketing and Communications

40 E. Montgomery Avenue, 4 th Floor

Ardmore, PA 19003

Phone: 610-642-6550

Fax: 610-642-6559

Email: [email protected]

• Bright Pink

Lindsay Avner

Founder and Chairman of the Board

2045 W Grand Avenue, Suite B #54599

Chicago, IL 60612-1577

Phone: 312-787-4412

Email: [email protected]

FORCE: Facing Our Risk of Cancer Empowered

Verinda Hobbs

Partnership Strategy Manager

16057 Tampa Palms Boulevard W., PMB #373

Tampa, FL 33647

Phone: 954-255-8732

Email: [email protected]

Current Committee Member

The National Patient Advocate Foundation

Shonta chambers, msw.

Executive Vice President, Health Equity Initiatives and Programs

• Patient Advocate Foundation

421 Butler Farm Road

Hampton, VA 72366

Phone: 757-952-2544

Fax: 757-952-2533

Email: [email protected]

Adina Fleischmann, LSW, OSW-C

Chief Services Officer

1086 Teaneck Road, Site 2G

Teaneck, NJ 07666

Phone: 201-833-2341

Fax: 201-837-5025

Email: [email protected]

• Sisters Network, Inc.
• Susan G. Komen for the Cure

Susan Brown, MS, RN

Senior Director, Education & Patient Support

Susan G. Komen

5005 LBJ Freeway, Suite 526

Dallas, TX 75244

Phone: 972-855-1635

Email: [email protected]

• Tigerlily Foundation

Maimah S. Karmo

Chief Executive Officer

11654 Plaza America Drive, #725

Reston, VA 20190

Phone: 888-580-6253

Fax: 703-663-9844

Email: [email protected]

• Young Survival Coalition

Jennifer Merschdorf, MBA

80 Broad Street, Suite 1700

New York, NY 10004

Phone: 646-257-3001

Fax: 646-257-3030

Email: [email protected]

Liaison representative organizations

• Avon Foundation for Women

Breast Cancer

Talk to your doctor about when to start and how often to get a mammogram.

For Everyone

Public health.

NIH VideoCasting

CIT can broadcast your seminar, conference or meeting live to a world-wide audience over the Internet as a real-time streaming video. The event can be recorded and made available for viewers to watch at their convenience as an on-demand video or a downloadable file. CIT can also broadcast NIH-only or HHS-only content.

Related Videos...

Videocast send live feedback, advisory committee on research on women's health - october 2022, videocast downloader.

Download VideoCast

You can download this VideoCast and play it on your device. There are multiple sizes available for you to choose from. Select bitrate 150k 440k 740k 1040k 1240k 1840k

Download caption text

Putting science to work for the health of women

Event Details

Advancing nih research on the health of women: a 2021 conference, date and time.

Event hosted by the Advisory Committee on Research on Women’s Health (ACRWH).

• Event Information
• Speaker Bios and Videos
• Speaker Presentations

In response to a congressional request to address NIH efforts related to women’s health research, the Office of Research on Women’s Health (ORWH), in conjunction with the Advisory Committee on Research on Women’s Health (ACRWH), will be hosting “ Advancing NIH Research on the Health of Women: A 2021 Conference .” The key topics to be discussed, as identified by Congress, are (1) clinical practices related to rising maternal morbidity and mortality rates; (2) increasing rates of chronic debilitating conditions in women; and (3) stagnant cervical cancer survival rates. 

Conference Webpage

Welcome Letter

Event Videos Playlist

• Women's Health Matters: When, Where, and Why Video
• A Path Forward Toward Accelerating Cervical Cancer Eradication Video
• How Stereotypes Underpin Inequities for Women in Academic STEMM  and  Advancements in Women's Health Video
• Fibroids as a Female-Specific Chronic Debilitating Condition Video
• Introduction Video
• Root Causes of Maternal Health Outcomes and Research Justice Video
• Expanding Maternal Morbidity and Mortality Research Within & Beyond Our Hospital Walls Video
• Cross-Cutting Anti-Racist Approaches to Cancer Disparities Research Video
• Opportunities for Research to Reduce Disparities in Maternal Morbidity and Mortality Video
• Developing and Implementing Culturally Sensitive Care for Women Video
• Innovation Through the Lens of Women's Health Research: A Rising Tide Lifts All Boats! Video
• Opportunities in Clinical Research to Reduce Maternal Morbidity and Mortality Video
• The U.S. Maternal Health Care Crisis Video
• Impact of Chronic Disease: The Sex & Gender Gap Video
• The Future of Clinical Research in Cervical Cancer Treatment Video
• Clinical Trials in Cervical Cancer: Can They Be All That We Want Them to Be? Video
• How Can Research Findings Be Translated into Reduced Maternal Morbidity and Mortality Video
• NCI Clinical Trials in Gynecologic Cancer: A Changing Landscape Video
• What We Know About the Leading Killer of Women & What We Should Do About It! Video
• Fortifying Opportunities to Advance Female-Specific Chronic Disease Research Video
• Prevention of Chronic Conditions in Women to Advance Health and Function Across the Lifespan Video
• Welcome Video
• Translating Science into Improved Patient Care for Women with Cervical Cancer Video
• Harnessing the Power of Research: Optimizing Infrastructure to Optimize Maternal Outcomes Video
• Chronic Debilitating Conditions in Women: The Heart of the Matter Video
• Maternal Morbidity and Mortality: Tip of a Lifecourse Iceberg Video
• Cervical Cancer: How Can We Overcome Our History Video
• Improving Treatment for Cervical Cancer: What Can Tumor Biology Tell Us? Video
• Beyond Sex as a Biological Variable: Addressing Chronic Debilitating Conditions Video
• Chronic Debilitating Conditions on Women: Sex and Gender Impact on Osteoarthritis Video
• You Are What You Love: Prioritizing Women's Health Research for a Healthier Society Video
• The Future of Cervical Cancer Prevention in the United States Video
• Dr. Clayton
• Dr. Griffith
• Dr. Jenkins
• Dr. Wheeler
• Dr. Schwarz
• Dr. Templeton
• Dr. Catherino
• Dr. Missmer
• Dr. Regensteiner
• Dr. Giscombe
• Dr. Rich-Edwards
• Dr. D'Alton
• Dr. Wallace
• Dr. Crear-Perry

Director’s Messages

April 30, 2024

March 27, 2024

February 27, 2024

January 25, 2024